Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-20

Clinical Trial Update: Quadratus Lumborum Block by Paraspinous Sagittal Shift Approach With Different Concentrations Of Bupivacaine in Hip Surgeries [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating quadratus lumborum block via paraspinous sagittal shift with various bupivacaine concentrations for hip surgeries; status no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: Beni-Suef University | Conditions: Hip Surgeries | Phase 4 | Status: UNKNOWN